A novel combination therapy to reverse end-stage heart failure.
Yacoub
M H
MH
National Heart and Lung Institute at Imperial College of Science, Technology and Medicine, Royal Brompton and Harefield Hospital, Harefield, Middlesex, United Kingdom.
Tansley
P
P
Birks
E J
EJ
Banner
N R
NR
Khaghani
A
A
Bowles
C
C
Banner
W R
WR
Khaghan
A
A
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003971:Diastole; D004452:Echocardiography; D006333:Heart Failure / Q000503:physiopathology / Q000628:therapy*; D006353:Heart-Assist Devices; D006801:Humans; D013599:Systole; D013927:Thrombosis / Q000517:prevention & control; D018487:Ventricular Dysfunction, Left / Q000628:therapy*; D016277:Ventricular Function, Left / Q000502:physiology*
D000319:Adrenergic beta-Antagonists